Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants: Reducing Harms
Abstract:
An increase in attention-deficit/hyperactivity disorder (ADHD) diagnoses since 2020, along with shortages in prescription stimulants and an increase in overdose deaths from stimulants, has triggered alarm within the public sector, regulatory agencies, and health care systems. Stimulants are classified as Schedule II drugs by the Drug Enforcement Administration due to the potential for misuse and physiological and psychological dependence. Despite concerns, stimulants are effective first-line treatments for children and adults with ADHD. The majority of deaths related to stimulants are linked to misuse of illicitly manufactured stimulants that may contain the synthetic opioid, fentanyl. The current article provides a brief overview of the problem, along with clinical strategies for preventing and reducing harm. [Journal of Psychosocial Nursing and Mental Health Services, 63(3), 7-10.].
More Related Videos
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
